JTK-101

Overview

JTK-101 is a selective HIV inhibitor. JTK-101 selectively reduces HIV-1 mRNA synthesis by inhibiting Tat cofactors, including CDK9 and cyclin T1 , thereby suppressing the transcriptional activity of HIV-1 . JTK-101 may be used in the field of anti-HIV virus research.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > HIV | Products > Signaling Pathways > CDK

Product Information

• Catalog No.: HY-119120
• CAS No.: 503048-34-8
• Molecular Formula: C25H23N3O3
• Molecular Weight: 413.47
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source